Engineers Gate Manager’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,402	Closed	-$280K	–	2203
2025 Q1	$280K	Buy	15,402 +3,913	+34%	+$87.4K	﹤0.01%	1747
2024 Q4	$290K	Sell	11,489 -26,997	-70%	-$733K	0.01%	1714
2024 Q3	$1.31M	Buy	38,486 +30,732	+396%	+$1.17M	0.03%	848
2024 Q2	$287K	Sell	7,754 -18,852	-71%	-$711K	0.01%	1496
2024 Q1	$1.12M	Buy	26,606 +17,536	+193%	+$720K	0.03%	763
2023 Q4	$360K	Sell	9,070 -4,583	-34%	-$135K	0.01%	1351
2023 Q3	$376K	Buy	+13,653	New	+$428K	0.01%	1211
2023 Q2	–	Sell	-8,227	Closed	-$296K	–	1767
2023 Q1	$296K	Buy	+8,227	New	+$355K	0.01%	1244
2022 Q4	–	Sell	-12,317	Closed	-$346K	–	1714
2022 Q3	$346K	Buy	+12,317	New	+$378K	0.02%	1031
2022 Q2	–	Sell	-7,086	Closed	-$241K	–	1951
2022 Q1	$241K	Buy	+7,086	New	+$227K	0.01%	1536
2016 Q1	–	Sell	-735	Closed	-$173K	–	691
2015 Q4	$173K	Buy	+735	New	+$160K	0.01%	612